E. Omuraliev
E. Omuraliev has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A. Dzhanaliev
Kyrgyz-Russian Slavic University
1 shared publication - Dzhyldyz Ibraimova
Department of Public Health and Health Care, Kyrgyz-Russian Slavic University Named After B.N. Yeltsin, Bishkek 720000, Kyrgyzstan
1 shared publication - O. A. Bolbachan
Kyrgyz-Russian Slavic University
1 shared publication
Latest Publications
- 15 June 2026
- Published by Publishing Center Science and Practice in Bulletin of Science and Practice
- Vol. 12 (6) , 258-268
Clinical and Statistical Characteristics of the Structure of Morbidity and Hospitalization Outcomes in the Pre-Pandemic and Post-Pandemic Periods (2019–2023)
The COVID-19 pandemic has altered the structure of hospitalizations and outcomes of inpatient care. A national analysis of in-hospital mortality makes it possible to assess the scale of COVID-19 impact and compare it with other viral infections. To compare in-hospital mortality in COVID-19 (U07.1/U07.2) and other viral infections (B34) in the Kyrgyz Republic in 2019–2023. Materials and methods. A retrospective study was conducted based on hospital data of the Kyrgyz Republic for 2019–2023. The following groups were analyzed: COVID-19 (U07.1/U07.2) and B34. In-hospital mortality rates, relative risk (RR) of death, and 95% confidence intervals (95% CI) were calculated. In 2020–2023, in-hospital mortality for COVID-19 was: 2020 — 4.36% (36,629; 1,596), 2021 — 4.44% (26,307; 1,168), 2022 — 5.92% (6,186; 366), 2023 — 1.57% (254; 4). In the B34 group, mortality was significantly lower: 2019 — 0.13% (6,348; 8), 2020 — 0.25% (2,034; 5), 2021 — 0.13% (3,850; 5), 2022 — 0.10% (9,111; 9), 2023 — 0.12% (13,190; 16). The risk of death in COVID-19 was significantly higher compared to B34: RR 2020 — 17.73 (95% CI 7.38–42.60), 2021 — 34.19 (14.21–82.24), 2022 — 59.90 (30.94–115.95), 2023 — 12.98 (4.37–38.56). At the national level, COVID-19 was associated with a multiple increase in in-hospital mortality compared to other viral infections, with peak values observed in 2022. The findings can be used for hospital preparedness planning and monitoring of severe infectious conditions.
- 15 June 2026
- Published by Publishing Center Science and Practice in Bulletin of Science and Practice
- Vol. 12 (6) , 258-268
Clinical and Statistical Characteristics of the Structure of Morbidity and Hospitalization Outcomes in the Pre-Pandemic and Post-Pandemic Periods (2019–2023)
The COVID-19 pandemic has altered the structure of hospitalizations and outcomes of inpatient care. A national analysis of in-hospital mortality makes it possible to assess the scale of COVID-19 impact and compare it with other viral infections. To compare in-hospital mortality in COVID-19 (U07.1/U07.2) and other viral infections (B34) in the Kyrgyz Republic in 2019–2023. Materials and methods. A retrospective study was conducted based on hospital data of the Kyrgyz Republic for 2019–2023. The following groups were analyzed: COVID-19 (U07.1/U07.2) and B34. In-hospital mortality rates, relative risk (RR) of death, and 95% confidence intervals (95% CI) were calculated. In 2020–2023, in-hospital mortality for COVID-19 was: 2020 — 4.36% (36,629; 1,596), 2021 — 4.44% (26,307; 1,168), 2022 — 5.92% (6,186; 366), 2023 — 1.57% (254; 4). In the B34 group, mortality was significantly lower: 2019 — 0.13% (6,348; 8), 2020 — 0.25% (2,034; 5), 2021 — 0.13% (3,850; 5), 2022 — 0.10% (9,111; 9), 2023 — 0.12% (13,190; 16). The risk of death in COVID-19 was significantly higher compared to B34: RR 2020 — 17.73 (95% CI 7.38–42.60), 2021 — 34.19 (14.21–82.24), 2022 — 59.90 (30.94–115.95), 2023 — 12.98 (4.37–38.56). At the national level, COVID-19 was associated with a multiple increase in in-hospital mortality compared to other viral infections, with peak values observed in 2022. The findings can be used for hospital preparedness planning and monitoring of severe infectious conditions.